{"denomUnitsSelected":"Participants","description":"Rimiducid Use","reportingStatus":"NOT_POSTED","timeFrame":"Baseline through Month 24","title":"Phase 2: Evaluate Efficacy Endpoints (R)","type":"SECONDARY"}